No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
IBB240726C146000
- 1.50
- +0.85+130.77%
15min DelayClose Jul 22 16:00 ET
1.50High0.72Low
0.75Open0.65Pre Close40 Volume28 Open Interest146.00Strike Price3.47KTurnover20.16%IV0.86%PremiumJul 26, 2024Expiry Date0.24Intrinsic Value100Multiplier4DDays to Expiry1.26Extrinsic Value100Contract SizeAmericanOptions Type0.5457Delta0.1259Gamma102.62Leverage Ratio-0.1714Theta0.0089Rho56.00Eff Leverage0.0619Vega
Intraday
- 5D
- Daily
News
Sector Update: Health Care Stocks Rise in Monday's Premarket Hours
Health care stocks were advancing premarket Monday with the Health Care Select Sector SPDR Fund (XLV) 0.3% higher and the iShares Biotechnology ETF (IBB) up 0.5% recently.IQVIA Holdings (IQV) was up
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Friday as Global IT Outage Recovery Begins
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% higher in Friday's premarket activity, as computer systems
Sector Update: Health Care Stocks Edge Lower Premarket Thursday
Health care stocks were lower premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) 0.1% down and the iShares Biotechnology ETF (IBB) marginally declining recently.OPKO Health (OPK)
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday as Tech Stocks Recover
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% higher in Thursday's premarket activity, as tech stocks
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
Health care stocks were leaning lower premarket Wednesday, with the Health Care Select Sector SPDR Fund (XLV) declining 0.8% and the iShares Biotechnology ETF (IBB) down 1.1% recently.4D Molecular
Sector Update: Health Care Stocks Rise Pre-Bell Tuesday
Health care stocks were higher pre-bell Tuesday as the Health Care Select Sector SPDR Fund (XLV) was up 0.3% and the iShares Biotechnology ETF (IBB) was 0.5% higher recently.Silo Pharma (SILO)
Comments
$iShares Biotechnology ETF(IBB.US$
Buy this ETF before the biotechnology boom will come next time
Buy this ETF before the biotechnology boom will come next time
$SPDR S&P Biotech ETF(XBI.US$ $iShares Biotechnology ETF(IBB.US$
M&A in Q1 alone totaled 12 deals for $19.2 bil which is close to the 10 deals for $21.9 bil in all the 1H of 2023...
But one big caveat of this chart, it doesn't include $Pfizer(PFE.US$ 's $43 bil deal for $SGEN announced in Mar 2023 but didn't close until Dec bc of an FTC challenge,
The biggest biotech M&A deal so far this yr was $Gilead Sciences(GILD.US$ 's $4.3 b...
M&A in Q1 alone totaled 12 deals for $19.2 bil which is close to the 10 deals for $21.9 bil in all the 1H of 2023...
But one big caveat of this chart, it doesn't include $Pfizer(PFE.US$ 's $43 bil deal for $SGEN announced in Mar 2023 but didn't close until Dec bc of an FTC challenge,
The biggest biotech M&A deal so far this yr was $Gilead Sciences(GILD.US$ 's $4.3 b...
6
$SPDR S&P Biotech ETF(XBI.US$ $iShares Biotechnology ETF(IBB.US$
Observations from $VINC (-60% AH):
1- When companies tout "strong safety profile", often means efficacy is a big fat zero
2- Phrases like "dose dependent clinical activity" set the bar low
3- "Promising" doesn't necessarily refer to SP
Stay skeptical, my friends.
Observations from $VINC (-60% AH):
1- When companies tout "strong safety profile", often means efficacy is a big fat zero
2- Phrases like "dose dependent clinical activity" set the bar low
3- "Promising" doesn't necessarily refer to SP
Stay skeptical, my friends.
3
$SPDR S&P Biotech ETF(XBI.US$ $iShares Biotechnology ETF(IBB.US$
Mike on biotech's correlation with interest rates:
"Biotech is essentially a call option on $iShares 20+ Year Treasury Bond ETF(TLT.US$
Biotech bulls need inflation and rates to move lower for resumption of a real bull market.
XBI is likely to remain range-bound - or worse - until inflation convincingly moves lower.
Hopefully we can grind out reasonable returns in the meantime by buying the right stocks, but we will b...
Mike on biotech's correlation with interest rates:
"Biotech is essentially a call option on $iShares 20+ Year Treasury Bond ETF(TLT.US$
Biotech bulls need inflation and rates to move lower for resumption of a real bull market.
XBI is likely to remain range-bound - or worse - until inflation convincingly moves lower.
Hopefully we can grind out reasonable returns in the meantime by buying the right stocks, but we will b...
5
Since the beginning of this year, $NVIDIA(NVDA.US$ has been leading a group of semiconductor and AI stocks to further rise in response to the breakthroughs in AI technology and a booming industry outlook. However, an increasing number of investors have started to fret over the potential risks behind the high valuations of AI stocks and are scouting for alternative investment opportunities. Some of them have shifted their focus to biotech stocks...
61
3
Read more